Article
Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies
30 Oct 2025
Abstract excerpt
The rapid evolution of sequencing technologies has profoundly advanced precision oncology. Whole-exome sequencing (WES), whole-genome sequencing (WGS), and whole-transcriptome sequencing (RNA-Seq) enable comprehensive characterization of tumor biology by detecting actionable mutations, gene fusions, splice variants, copy number alterations, and pathway dysregulation. These approaches also provide critical...
Topics
Join the communities discussing this publication.